HIKAL.NS
Hikal Limited [HIKAL.NS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
HIKAL.NS Stock Summary
Top 10 Correlated ETFs
HIKAL.NS
Top 10 Correlated Stocks
HIKAL.NS
In the News
HIKAL.NS Financial details
Company Rating
Buy
Market Cap
37.26B
Income
716.22M
Revenue
18.03B
Book val./share
-
Cash/share
-
Dividend
1.2
Dividend %
0.4%
Employees
2.14K
Optionable
No
Shortable
Yes
Earnings
27 May 2024
P/E
44.84
Forward P/E
-
PEG
-8.1
P/S
1.94
P/B
3.21
P/C
-
P/FCF
-
Quick Ratio
0.63
Current Ratio
1.28
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
5.81
EPS next Y
-
EPS next Q
-
EPS this Y
-51.15%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-5.32%
Revenue last 5Y
4.77%
Revenue Q/Q
3.79%
EPS Q/Q
28.43%
-
-
-
-
SMA20
10.26%
SMA50
3.44%
SMA100
10.26%
Inst Own
-
Inst Trans
-
ROA
3%
ROE
14%
ROC
0.1%
Gross Margin
50%
Oper. Margin
9%
Profit Margin
4%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
250.1-329.0
52W High
-9.26%
52W Low
+19.42%
RSI
61
Rel Volume
1.07
Avg Volume
224.61K
Volume
239.3K
Perf Week
-0.35%
Perf Month
6.93%
Perf Quarter
10.15%
Perf Half Y
3%
-
-
-
-
Beta
1.143
-
-
Volatility
1.96%, 13.07%
Prev Close
-1.47%
Price
298.55
Change
-0.32%
HIKAL.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
| Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 128.78 | 122.08 | 138.45 | 156.21 | 162.59 | |
| Net income per share | 8.36 | 6.85 | 10.8 | 13.02 | 6.36 | |
| Operating cash flow per share | 15.05 | 23.11 | 18.57 | 23.82 | 25.57 | |
| Free cash flow per share | 4.64 | 10.29 | 5.79 | 1.66 | 1.03 | |
| Cash per share | 2.56 | 2.59 | 1.36 | 1.76 | 6.18 | |
| Book value per share | 61.33 | 66.22 | 75.7 | 86.62 | 91.93 | |
| Tangible book value per share | 60.66 | 65.34 | 74.87 | 85.78 | 91.1 | |
| Share holders equity per share | 61.33 | 66.22 | 75.7 | 86.62 | 91.93 | |
| Interest debt per share | 57.47 | 56.12 | 52.08 | 56.87 | 64.58 | |
| Market cap | 22.41B | 8.59B | 17.7B | 49.6B | 34.73B | |
| Enterprise value | 28.91B | 14.73B | 23.73B | 56.24B | 41.94B | |
| P/E ratio | 21.74 | 10.17 | 13.29 | 30.91 | 44.31 | |
| Price to sales ratio | 1.41 | 0.57 | 1.04 | 2.58 | 1.73 | |
| POCF ratio | 12.08 | 3.01 | 7.73 | 16.89 | 11.01 | |
| PFCF ratio | 39.2 | 6.77 | 24.78 | 242.93 | 273.66 | |
| P/B Ratio | 2.96 | 1.05 | 1.9 | 4.64 | 3.06 | |
| PTB ratio | 2.96 | 1.05 | 1.9 | 4.64 | 3.06 | |
| EV to sales | 1.82 | 0.98 | 1.39 | 2.92 | 2.09 | |
| Enterprise value over EBITDA | 9.84 | 5.44 | 7.31 | 16.53 | 15.98 | |
| EV to operating cash flow | 15.57 | 5.17 | 10.36 | 19.15 | 13.3 | |
| EV to free cash flow | 50.57 | 11.61 | 33.22 | 275.43 | 330.51 | |
| Earnings yield | 0.05 | 0.1 | 0.08 | 0.03 | 0.02 | |
| Free cash flow yield | 0.03 | 0.15 | 0.04 | 0 | 0 | |
| Debt to equity | 0.87 | 0.79 | 0.65 | 0.63 | 0.66 | |
| Debt to assets | 0.39 | 0.37 | 0.32 | 0.31 | 0.31 | |
| Net debt to EBITDA | 2.21 | 2.27 | 1.86 | 1.95 | 2.75 | |
| Current ratio | 1.38 | 1.3 | 1.34 | 1.25 | 1.42 | |
| Interest coverage | 4.42 | 4.13 | 7.46 | 9.36 | 3.09 | |
| Income quality | 1.24 | 2.01 | 1.11 | 1.34 | 2.99 | |
| Dividend Yield | 0.01 | 0.03 | 0.01 | 0.01 | 0 | |
| Payout ratio | 0.16 | 0.28 | 0.11 | 0.17 | 0.16 | |
| Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | |
| Research and developement to revenue | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | |
| Intangibles to total assets | 0 | 0.01 | 0.01 | 0 | 0 | |
| Capex to operating cash flow | -0.69 | -0.55 | -0.69 | -0.93 | -0.96 | |
| Capex to revenue | -0.08 | -0.1 | -0.09 | -0.14 | -0.15 | |
| Capex to depreciation | -1.38 | -1.92 | -1.85 | -2.86 | -2.78 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 107.41 | 101.01 | 135.62 | 159.27 | 114.67 | |
| ROIC | 0.1 | 0.09 | 0.1 | 0.1 | 0.06 | |
| Return on tangible assets | 0.06 | 0.05 | 0.07 | 0.07 | 0.03 | |
| Graham Net | -32.76 | -41 | -36.51 | -47.77 | -55.62 | |
| Working capital | 2.27B | 1.78B | 2.22B | 1.95B | 2.77B | |
| Tangible asset value | 7.48B | 8.06B | 9.23B | 10.58B | 11.23B | |
| Net current asset value | -992.66M | -1.77B | -1.01B | -1.81B | -3.13B | |
| Invested capital | 0.87 | 0.79 | 0.65 | 0.63 | 0.66 | |
| Average receivables | 3.76B | 3.8B | 4.25B | 5B | 4.68B | |
| Average payables | 1.63B | 1.81B | 2.15B | 2.39B | 2.81B | |
| Average inventory | 3.34B | 3.38B | 2.9B | 2.98B | 3.23B | |
| Days sales outstanding | 95.54 | 83.33 | 108.19 | 93.46 | 80.48 | |
| Days payables outstanding | 66.72 | 91.6 | 89.48 | 87.98 | 103.29 | |
| Days of inventory on hand | 150.9 | 142.29 | 103.93 | 116.21 | 104.43 | |
| Receivables turnover | 3.82 | 4.38 | 3.37 | 3.91 | 4.54 | |
| Payables turnover | 5.47 | 3.98 | 4.08 | 4.15 | 3.53 | |
| Inventory turnover | 2.42 | 2.57 | 3.51 | 3.14 | 3.5 | |
| ROE | 0.14 | 0.1 | 0.14 | 0.15 | 0.07 | |
| Capex per share | -10.42 | -12.82 | -12.78 | -22.17 | -24.54 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 43.67 | 43.63 | 31.32 | 34.97 | 36.3 | |
| Net income per share | 2.14 | 2.92 | 0.56 | 1.02 | 1.31 | |
| Operating cash flow per share | 4.59 | 4.35 | 4.5 | 4.63 | 4.7 | |
| Free cash flow per share | 4.59 | 4.35 | 4.5 | 4.63 | 4.7 | |
| Cash per share | 4.11 | 6.18 | 4.83 | 3.94 | 0 | |
| Book value per share | 87.56 | 91.93 | 91.93 | 92.88 | 0 | |
| Tangible book value per share | 0 | 91.1 | 0 | 91.97 | 0 | |
| Share holders equity per share | 87.56 | 91.93 | 91.93 | 92.88 | 0 | |
| Interest debt per share | 1.06 | 61.73 | 1.12 | 63.79 | 1.15 | |
| Market cap | 50.57B | 34.73B | 38.65B | 36.42B | 37.01B | |
| Enterprise value | 51.07B | 41.94B | 39.24B | 44.05B | 37.01B | |
| P/E ratio | 47.87 | 24.12 | 139.63 | 72.44 | 57.33 | |
| Price to sales ratio | 9.39 | 6.46 | 10.01 | 8.45 | 8.27 | |
| POCF ratio | 89.43 | 64.72 | 69.69 | 63.74 | 63.88 | |
| PFCF ratio | 89.43 | 64.72 | 69.69 | 63.74 | 63.88 | |
| P/B Ratio | 4.68 | 3.06 | 3.41 | 3.18 | 0 | |
| PTB ratio | 4.68 | 3.06 | 3.41 | 3.18 | 0 | |
| EV to sales | 9.49 | 7.8 | 10.16 | 10.21 | 8.27 | |
| Enterprise value over EBITDA | 66.25 | 47.45 | 76.6 | 75.28 | 57.16 | |
| EV to operating cash flow | 90.33 | 78.16 | 70.76 | 77.09 | 63.88 | |
| EV to free cash flow | 90.33 | 78.16 | 70.76 | 77.09 | 63.88 | |
| Earnings yield | 0.01 | 0.01 | 0 | 0 | 0 | |
| Free cash flow yield | 0.01 | 0.02 | 0.01 | 0.02 | 0.02 | |
| Debt to equity | 0 | 0.66 | 0 | 0.68 | 0 | |
| Debt to assets | 0 | 0.31 | 0 | 0.32 | 0 | |
| Net debt to EBITDA | 0.66 | 8.16 | 1.16 | 13.03 | 0 | |
| Current ratio | 0 | 1.42 | 0 | 1.28 | 0 | |
| Interest coverage | 3.75 | 4.74 | 1.64 | 2.29 | 2.51 | |
| Income quality | 2.14 | 1.49 | 8.01 | 4.55 | 3.59 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0.22 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 64.96 | 77.7 | 34.07 | 46.16 | 0 | |
| ROIC | 0.03 | 0.02 | 0.01 | 0.01 | 0 | |
| Return on tangible assets | 0 | 0.02 | 0 | 0.01 | 0 | |
| Graham Net | 4.11 | -55.62 | 4.83 | -58.17 | 0 | |
| Working capital | 506.7M | 2.77B | 595.5M | 1.95B | 0 | |
| Tangible asset value | 0 | 11.23B | 0 | 11.34B | 0 | |
| Net current asset value | 506.7M | -3.13B | 595.5M | -3.52B | 0 | |
| Invested capital | 0 | 0.66 | 0 | 0.68 | 0 | |
| Average receivables | 2.45B | 2.21B | 2.21B | 1.97B | 1.97B | |
| Average payables | 1.25B | 1.57B | 1.57B | 1.48B | 1.48B | |
| Average inventory | 1.64B | 1.58B | 1.58B | 1.84B | 1.84B | |
| Days sales outstanding | 0 | 73.96 | 0 | 82.34 | 0 | |
| Days payables outstanding | 0 | 100.78 | 0 | 124.92 | 0 | |
| Days of inventory on hand | 0 | 101.9 | 0 | 155.27 | 0 | |
| Receivables turnover | 0 | 1.22 | 0 | 1.09 | 0 | |
| Payables turnover | 0 | 0.89 | 0 | 0.72 | 0 | |
| Inventory turnover | 0 | 0.88 | 0 | 0.58 | 0 | |
| ROE | 0.02 | 0.03 | 0.01 | 0.01 | 0 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
HIKAL.NS Frequently Asked Questions
What is Hikal Limited stock symbol ?
Hikal Limited is a IN stock and trading under the symbol HIKAL.NS
What is Hikal Limited stock quote today ?
Hikal Limited stock price is $298.55 today.
Is Hikal Limited stock public?
Yes, Hikal Limited is a publicly traded company.
Something similar
Company Profile
- Volume Average 224.61K
- Market Capitalization 37.26B
- Employee 2.14K
- CEO Mr. Jai Vishwanath Hiremath
- Headquarters Navi Mumbai,IN
- IPO Date 2002-07-01
-
Website
https://www.hikal.com 
Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal healthcare, biotech, crop protection, and specialty chemicals companies. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredient (APIs). The Crop Protection segment manufactures pesticides and herbicides. The company collaborates with other companies and offer solutions in contract research, custom synthesis, and custom manufacturing of intermediates and APIs. It also provides specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company was incorporated in 1988 and is headquartered in Navi Mumbai, India.
